SCHEMBL6513847

SCHEMBL6513847

NC1C(=O)NC1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513851 1.00
Acetic Acid SCHEMBL17093926 0.89 GLA (0.31)
SCHEMBL15031115 0.82 GLA (0.41)
SCHEMBL13339121 0.82 GLA (0.41)
SCHEMBL13367189 0.82 GLA (0.41)
SCHEMBL17136795 0.79 IRAK4 (0.38)
SCHEMBL10876688 0.75
SCHEMBL17107895 0.75
SCHEMBL9702796 0.75
Hydrochloric Acid SCHEMBL9725129 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992013837-A1 A PROCESS FOR THE PREPARATION OF 3-ACYLAMINO-4-CARBAMOYLOXYMETHYL-2-AZETIDINONE-1-SULPHONIC ACIDS AND INTERMEDIATES FOR THE PREPARATION THEREOF ISTITUTO LUSO FARMACO D'ITALIA S.P.A. (IT) 1992-08-20 WO claimed
US-20050123533-A1 Prodrugs activated by targeted catalytic proteins WELLSTAT BIOCATALYSIS, LLC 2005-06-09 US disclosed
US-6702705-B1 Prodrugs activated by targeted catalytic proteins IGEN INTERNATIONAL, INC. 2004-03-09 US disclosed
US-20030096765-A1 Prodrugs activated by targeted catalytic proteins IGEN, INC. 2003-05-22 US disclosed
US-6258360-B1 BENZOATE CONJUGATES; ANTITUMOR AGENTS IGEN INTERNATIONAL, INC. 2001-07-10 US disclosed
EP-0746336-A1 PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS IGEN, INC. (US) 1996-12-11 EP disclosed
EP-0746336-A4 PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS IGEN INC (US) 1996-07-26 EP disclosed
EP-0362902-B1 Process and intermediates for beta-lactam antibiotics HARVARD COLLEGE (US) 1996-01-17 EP disclosed
WO-1993002703-A1 PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS IGEN, INC. (US) 1993-02-18 WO disclosed
WO-1992013837-A1 A PROCESS FOR THE PREPARATION OF 3-ACYLAMINO-4-CARBAMOYLOXYMETHYL-2-AZETIDINONE-1-SULPHONIC ACIDS AND INTERMEDIATES FOR THE PREPARATION THEREOF ISTITUTO LUSO FARMACO D'ITALIA S.P.A. (IT) 1992-08-20 WO disclosed
EP-0053816-B1 1-SULFO-2-OXOAZETIDINE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1988-05-04 EP disclosed
US-4734495-A Process and intermediates for beta-lactam antibiotics PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1988-03-29 US disclosed
WO-1987007273-A2 N-1 SUBSTITUTED SULFONYLAMINOCARBONYL, C-4 SUBSTITUTED MONOBACTAMS THE UPJOHN COMPANY (US) 1987-12-03 WO disclosed
EP-0246786-A1 N-1 subsituted sulfonylaminocarbonyl, C-4 substituted monobactams THE UPJOHN COMPANY (US) 1987-11-25 EP disclosed
US-4675397-A MICROBIOCIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-06-23 US disclosed
US-4665067-A BACTERICIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-05-12 US disclosed
US-4665171-A CARBACEPHALOSPORINS HARVARD UNIVERSITY (US) 1987-05-12 US disclosed
EP-0209352-A2 Process and intermediates for beta-lactam antibiotics THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1987-01-21 EP disclosed
US-4550105-A BETA-LACTAMASE INHIBITORS, ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-10-29 US disclosed
EP-0053816-A1 1-Sulfo-2-oxoazetidine derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1982-06-16 EP disclosed